The National Institutes of Health (NIH) is seeking the next generation of Covid-19 diagnostics, with a focus on improved performance and accessibility.
As part of this move, NIH has granted two new funding opportunities, which are part of the Rapid Acceleration of Diagnostics (RADx) Tech programme, for diagnostic manufacturers to develop tests for Covid-19.
Managed by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the RADx Tech programme was introduced to expedite the development, commercialisation and implementation of Covid-19 testing technologies.
